COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03294135
Brief Title: The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

First Submitted : September 22, 2017
First Submitted that Met QC Criteria : September 22, 2017
First Posted : September 26, 2017

Last Update Submitted that Met QC Criteria : October 3, 2019
Last Update Posted : October 4, 2019